Literature DB >> 9413175

Cellular thioredoxin reductase activity is regulated by selenium.

M Berggren1, A Gallegos, J Gasdaska, G Powis.   

Abstract

Selenium (Se) is an essential trace element and has been reported to decrease the incidence of some human cancers. We have investigated the effects of Se on thioredoxin reductase, a selenocysteine containing flavoenzyme, in HT-29 human colon cancer cells grown in serum-free medium. Sodium selenite and other Se containing compounds produced a time and concentration dependent increase in intracellular thioredoxin reductase activity and protein levels. Selenite was the most active of the Se compounds examined: 1 microM selenite produced a 28-fold increase in thioredoxin reductase activity by 1 day and 10 microM selenite over a 60-fold increase by 5 days. The activity of a related non-selenocysteine containing flavoenzyme glutathione reductase was not increased by selenite. Selenite, but not the other Se containing compounds inhibited cell growth at concentrations above 2 microM. The results show that Se can produce large increases in cell thioredoxin reductase activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9413175

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Methylation of the ribosyl moiety at position 34 of selenocysteine tRNA[Ser]Sec is governed by both primary and tertiary structure.

Authors:  L K Kim; T Matsufuji; S Matsufuji; B A Carlson; S S Kim; D L Hatfield; B J Lee
Journal:  RNA       Date:  2000-09       Impact factor: 4.942

Review 2.  Thioredoxin reductase.

Authors:  D Mustacich; G Powis
Journal:  Biochem J       Date:  2000-02-15       Impact factor: 3.857

3.  Murine hepatoma (Hepa1c1c7) cells: a responsive in vitro system for chemoprotective enzyme induction by organoselenium compounds.

Authors:  Wael M El-Sayed; Tarek Aboul-Fadl; Jeanette C Roberts; John G Lamb; Michael R Franklin
Journal:  Toxicol In Vitro       Date:  2006-10-07       Impact factor: 3.500

4.  Sodium selenite increases the activity of the tumor suppressor protein, PTEN, in DU-145 prostate cancer cells.

Authors:  Margareta Berggren; Sivanandane Sittadjody; Zuohe Song; Jean-Louis Samira; Randy Burd; Emmanuelle J Meuillet
Journal:  Nutr Cancer       Date:  2009       Impact factor: 2.900

5.  Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence.

Authors:  L Zhong; E S Arnér; A Holmgren
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

6.  Thioredoxin reductase 1 ablation sensitizes colon cancer cells to methylseleninate-mediated cytotoxicity.

Authors:  Matthew Honeggar; Robert Beck; Philip J Moos
Journal:  Toxicol Appl Pharmacol       Date:  2009-09-24       Impact factor: 4.219

7.  Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.

Authors:  Garth Powis; Peter Wipf; Stephen M Lynch; Anne Birmingham; D Lynn Kirkpatrick
Journal:  Mol Cancer Ther       Date:  2006-03       Impact factor: 6.261

8.  Effect of thioredoxin deletion and p53 cysteine replacement on human p53 activity in wild-type and thioredoxin reductase null yeast.

Authors:  Christopher S Stoner; George D Pearson; Ahmet Koç; Jason R Merwin; Nathan I Lopez; Gary F Merrill
Journal:  Biochemistry       Date:  2009-09-29       Impact factor: 3.162

Review 9.  Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart.

Authors:  Md Kaimul Ahsan; Istvan Lekli; Diptarka Ray; Junji Yodoi; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-11       Impact factor: 8.401

10.  Overproduction of selenocysteine tRNA in Chinese hamster ovary cells following transfection of the mouse tRNA[Ser]Sec gene.

Authors:  M E Moustafa; M A El-Saadani; K M Kandeel; D B Mansur; B J Lee; D L Hatfield; A M Diamond
Journal:  RNA       Date:  1998-11       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.